MK6-83

MK6-83
Identifiers
	IUPAC name 5-methyl-N-[2-(piperidin-1-yl)phenyl]thiophene-2-sulfonamide;
CAS Number	1062271-24-2;
PubChem CID	18191179;
ChemSpider	17030252;
Chemical and physical data
Formula	C16H20N2O2S2
Molar mass	336.47 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=CC=C(S1)S(=O)(=O)NC2=CC=CC=C2N3CCCCC3;
	InChI InChI=1S/C16H20N2O2S2/c1-13-9-10-16(21-13)22(19,20)17-14-7-3-4-8-15(14)18-11-5-2-6-12-18/h3-4,7-10,17H,2,5-6,11-12H2,1H3; Key:IRGYSXZCDAWOOC-UHFFFAOYSA-N;

MK6-83 is a chemical compound which acts as a channel opener for the TRPML family of calcium channels, with moderate selectivity for TRPML1 over the related TRPML2 and TRPML3 subtypes.[1][2][3]

References

Kilpatrick BS, Yates E, Grimm C, Schapira AH, Patel S (October 2016). "Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and Ca2+ influx". Journal of Cell Science. 129 (20): 3859–3867. doi:10.1242/jcs.190322. PMID 27577094.
Morelli MB, Amantini C, Tomassoni D, Nabissi M, Arcella A, Santoni G (April 2019). "Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient's Survival". Cancers. 11 (4). doi:10.3390/cancers11040525. PMID 31013784.
Xia Z, Wang L, Li S, Tang W, Sun F, Wu Y, et al. (October 2020). "ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity". Antiviral Research. 182: 104922. doi:10.1016/j.antiviral.2020.104922. PMID 32858116.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Kilpatrick BS, Yates E, Grimm C, Schapira AH, Patel S (October 2016). "Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and Ca2+ influx". Journal of Cell Science. 129 (20): 3859–3867. doi:10.1242/jcs.190322. PMID 27577094.

[2] Morelli MB, Amantini C, Tomassoni D, Nabissi M, Arcella A, Santoni G (April 2019). "Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient's Survival". Cancers. 11 (4). doi:10.3390/cancers11040525. PMID 31013784.

[3] Xia Z, Wang L, Li S, Tang W, Sun F, Wu Y, et al. (October 2020). "ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity". Antiviral Research. 182: 104922. doi:10.1016/j.antiviral.2020.104922. PMID 32858116.

MK6-83

See also

References